ketorolac has been researched along with Adenocarcinoma of Lung in 1 studies
Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, JG | 1 |
| Scarpa, JR | 1 |
| Gupta, HV | 1 |
| Tan, KS | 1 |
| Mastrogiacomo, B | 1 |
| Dycoco, J | 1 |
| Caso, R | 1 |
| Jones, GD | 1 |
| Sanchez-Vega, F | 1 |
| Adusumilli, PS | 1 |
| Rocco, G | 1 |
| Isbell, JM | 1 |
| Bott, MJ | 1 |
| Irie, T | 1 |
| McCormick, PJ | 1 |
| Fischer, GW | 1 |
| Jones, DR | 1 |
| Mincer, JS | 1 |
1 other study available for ketorolac and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis.
Topics: Adenocarcinoma of Lung; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers, Tumor; Gene Regulatory | 2021 |